(-0.08%) 5 142.75 points
(-0.03%) 38 546 points
(-0.01%) 17 903 points
(-0.18%) $82.48
(1.67%) $2.06
(-1.03%) $2 333.40
(-2.04%) $27.10
(-0.51%) $956.60
(0.17%) $0.934
(0.41%) $11.03
(0.20%) $0.798
(-0.23%) $93.09
Live Chart Being Loaded With Signals
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company...
Stats | |
---|---|
आज की मात्रा | 3.76M |
औसत मात्रा | 3.84M |
बाजार मूल्य | 3 990.11B |
EPS | ¥0 ( 2024-02-07 ) |
अगली कमाई की तारीख | ( ¥17.50 ) 2024-05-13 |
Last Dividend | ¥21.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 40.46 |
ATR14 | ¥1.329 (0.05%) |
मात्रा सहसंबंध
Terumo Corporation सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Terumo Corporation सहसंबंध - मुद्रा/वस्त्र
Terumo Corporation वित्तीय
Annual | 2022 |
राजस्व: | ¥820.21B |
सकल लाभ: | ¥417.37B (50.89 %) |
EPS: | ¥59.50 |
FY | 2022 |
राजस्व: | ¥820.21B |
सकल लाभ: | ¥417.37B (50.89 %) |
EPS: | ¥59.50 |
FY | 2022 |
राजस्व: | ¥703.30B |
सकल लाभ: | ¥369.34B (52.52 %) |
EPS: | ¥117.45 |
FY | 2021 |
राजस्व: | ¥613.84B |
सकल लाभ: | ¥326.62B (53.21 %) |
EPS: | ¥102.33 |
Financial Reports:
No articles found.
Terumo Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥19.00 (N/A) |
¥0 (N/A) |
¥21.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.063 | 2000-03-28 |
Last Dividend | ¥21.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 48 | -- |
Total Paid Out | ¥341.63 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.34 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.44 | |
Div. Directional Score | 9.52 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8584.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7908.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7065.T | Ex Dividend Junior | 2023-08-30 | Annually | 0 | 0.00% | |
6373.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
5301.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4350.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3526.T | Ex Dividend Junior | 2024-03-28 | Sporadic | 0 | 0.00% | |
2753.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
9639.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8593.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.112 | 1.500 | 7.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0585 | 1.200 | 8.05 | 9.66 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.288 | [0.1 - 1] |
payoutRatioTTM | 0.323 | -1.000 | 6.77 | -6.77 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.62 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.466 | 1.500 | 8.52 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.134 | -1.500 | 7.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 45.48 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.186 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.513 | 1.000 | 4.79 | 4.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.146 | 1.000 | 9.08 | 9.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.592 | 1.000 | 7.82 | 7.82 | [0.2 - 2] |
assetTurnoverTTM | 0.523 | 0.800 | 9.84 | 7.88 | [0.5 - 2] |
Total Score | 12.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 40.53 | 1.000 | 6.01 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.288 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.223 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.323 | 1.500 | 6.77 | -6.77 | [0 - 1] |
pegRatioTTM | 2.74 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.151 | 1.000 | 8.72 | 0 | [0.1 - 0.5] |
Total Score | 6.44 |
Terumo Corporation
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं